Proleukin® (aldesleukin) is an immunotherapy that is indicated for the treatment of adults with metastatic melanoma (mM) and metastatic renal cell carcinoma (mRCC).

To learn more, visit


Erwinaze® (asparaginase Erwinia chrysanthemi) is an asparagine-specific enzyme indicated as a component of a multiagent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

To learn more, visit


Ethyol® (amifostine) is indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.

Ethyol is indicated to reduce the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer, where the radiation port includes a substantial portion of the parotid glands.


Totect® is a cytoprotective agent indicated for the treatment of extravasation resulting from intravenous anthracycline chemotherapy.